Latest News

Clinicians can bridge the gap between online trends and evidence-based outcomes by leveraging patient curiosity, emphasizing ingredient transparency, and delivering personalized in-office care.

AbbVie completed its $10.9 billion Apogee acquisition, adding IL-13 antibody zumilokibart and other inflammatory disease assets.

This review of the latest dermatological studies includes insights on adalimumab durability in HS, medicolegal issues in hair transplantation, yellow light and vitamin C for melasma, and more.

ACP outlines ethical AI in medicine: protect patient trust, fight bias, avoid deskilling, and disclose AI use as dermatology adopts new tools.

Dermatology Times is looking back on the top stories in dermatology from the month of August.

Explore the top headlines of the month, including insights on the latest clinical trials, therapeutic updates, and more.

Explore the top dermatology conferences and meetings happening this month and let us know which ones you'll be attending!

Dermatology Times debuts a dedicated NP/PA education platform and a new congress series, opening with Derm Nexus this November in Scottsdale, Arizona.

A twice-rejected melanoma immunotherapy finally won accelerated approval, acne's decades-long innovation drought moved a step closer to ending, and 2 rare, sun-triggered skin diseases picked up a deep-pocketed new sponsor.

Put your dermatology expertise to the test with Dermatology Times’ interactive quiz series.

Jennifer Soung, MD, discusses whole patient care for psoriasis and alopecia areata and why setting realistic expectations matters for hair regrowth.

Shawn Demehri, MD, PhD, discusses a calcipotriene/5-FU combination immunotherapy for field cancerization and its potential in organ transplant recipients.

Does "flooding" with 5 to 7 products every night really hydrate the skin or is it just a myth? Read more about the latest social media trend and learn how to counsel your patients in the clinic.